JP2011525483A - プロバイオティクス、分泌型IgA及び炎症 - Google Patents
プロバイオティクス、分泌型IgA及び炎症 Download PDFInfo
- Publication number
- JP2011525483A JP2011525483A JP2011514017A JP2011514017A JP2011525483A JP 2011525483 A JP2011525483 A JP 2011525483A JP 2011514017 A JP2011514017 A JP 2011514017A JP 2011514017 A JP2011514017 A JP 2011514017A JP 2011525483 A JP2011525483 A JP 2011525483A
- Authority
- JP
- Japan
- Prior art keywords
- siga
- lactobacillus
- probiotic
- use according
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【選択図】図1
Description
上皮細胞への結合
極性CACO−2細胞単層におけるバリア機能
極性CACO−2細胞単層におけるNF−κB活性化
抗病原体活性
極性Caco−2細胞単層における多量体Ig受容体の発現
Claims (13)
- 炎症を治療、軽減又は予防する製品の調製のための、SIgA及び少なくとも1種のプロバイオティクスを含む組成物の使用。
- 恒常性及び経口免疫寛容を生起、改善又は強化するための、請求項1に記載の使用。
- プロバイオティクスが、ビフィドバクテリウム、ラクトバチルス、ストレプトコッカス及びサッカロミセス、又はそれらの混合物からなる群より選択され、特に、ビフィドバクテリウム・ロンガム、ビフィドバクテリウム・ラクティス、ラクトバチルス・アシドフィルス、ラクトバチルス・ラムノサス、ラクトバチルス・パラカゼイ、ラクトバチルス・ジョンソニイ、ラクトバチルス・プランタルム、ラクトバチルス・サリバリウス、エンテロコッカス・フェシウム、サッカロミセス・ブラウディ及びラクトバチルス・ロイテリ、又はそれらの混合物からなる群より選択され、好ましくは、ラクトバチルス・ジョンソニイ(NCC533;CNCM I−1225)、ビフィドバクテリウム・ロンガム(NCC490;CNCM I−2170)、ビフィドバクテリウム・ロンガム(NCC2705;CNCM I−2618)、ビフィドバクテリウム・ラクティス(2818;CNCM I−3446)、ラクトバチルス・パラカゼイ(NCC2461;CNCM I−2116)、ラクトバチルス・ラムノサスGG(ATCC53103)、ラクトバチルス・ラムノサス(NCC4007;CGMCC 1.3724)、エンテロコッカス・フェシウムSF68(NCIMB10415)、及びそれらの混合物からなる群より選択される、請求項1又は2に記載の使用。
- 製品が、食物製品、動物用食物製品又は医薬組成物である、請求項1〜3のいずれか一項に記載の使用。
- 製品が、ヒト、特に幼児、若年者、成人又は高齢者によって消費されることを目的としたものである、請求項1〜4のいずれか一項に記載の使用。
- SIgA及び少なくとも1種のプロバイオティクスが、組成物中で少なくとも部分的に結合している、請求項1〜5のいずれか一項に記載の使用。
- 炎症反応の制御及び/又は軽減のための、請求項1〜6のいずれか一項に記載の使用。
- 組成物が、好ましくは乳酸菌、ビフィズス菌、腸球菌又はそれらの混合物からなる群より選択される、少なくとも1種の他の種類の他の食品用細菌を含む、請求項1〜7のいずれか一項に記載の使用。
- 製品が、好ましくはオリゴ糖類からなる群より選択される少なくとも1種のプレバイオティクスをさらに含む、請求項1〜8のいずれか一項に記載の使用。
- 製品が、日用量あたり細胞102〜1010個のプロバイオティクスを含む、請求項1〜9のいずれか一項に記載の使用。
- 製品が、日用量あたり0.0001mg〜10mgのSIgAを含む、請求項1〜10のいずれか一項に記載の使用。
- SIgA及び少なくとも1種のプロバイオティクス微生物を含む食品組成物。
- 少なくとも1種のプロバイオティクス微生物及びSIgAが複合体の形態で存在する、請求項12に記載の食品組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08158827A EP2138186A1 (en) | 2008-06-24 | 2008-06-24 | Probiotics, secretory IgA and inflammation |
EP08158827.9 | 2008-06-24 | ||
PCT/EP2009/057453 WO2009156301A1 (en) | 2008-06-24 | 2009-06-16 | Probiotics, secretory iga and inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2011525483A true JP2011525483A (ja) | 2011-09-22 |
Family
ID=39855103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011514017A Pending JP2011525483A (ja) | 2008-06-24 | 2009-06-16 | プロバイオティクス、分泌型IgA及び炎症 |
Country Status (11)
Country | Link |
---|---|
US (2) | US9822167B2 (ja) |
EP (3) | EP2138186A1 (ja) |
JP (1) | JP2011525483A (ja) |
CN (1) | CN102076360B (ja) |
AU (1) | AU2009264417B2 (ja) |
BR (1) | BRPI0914561A2 (ja) |
CA (1) | CA2727300A1 (ja) |
ES (2) | ES2641364T3 (ja) |
PL (1) | PL2318046T3 (ja) |
PT (2) | PT2318046E (ja) |
WO (1) | WO2009156301A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011525484A (ja) * | 2008-06-24 | 2011-09-22 | ネステク ソシエテ アノニム | プロバイオティクス、分泌型IgA及び感染症 |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2138186A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
RU2579500C2 (ru) * | 2011-07-12 | 2016-04-10 | Нестек С.А. | Пробиотик для введения здоровым младенцам млекопитающих во время периода отлучения от груди для улучшения толерантности к вновь вводимым продуктам питания |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CN102618461B (zh) * | 2012-03-09 | 2014-04-09 | 北京和美科盛生物技术有限公司 | 一株可以促进肠道中SIgA分泌的益生菌及其检测方法 |
US10010564B2 (en) * | 2012-09-11 | 2018-07-03 | Khaled Mahmood Al-Qaoud | Camel milk-based topical pharmaceutical composition |
US10278404B2 (en) * | 2012-09-11 | 2019-05-07 | Al-Urdonia Lemudaddat Al-Ajsam Co | Immunized camel milk-based composition for the treatment or prevention of gastrointestinal infections |
FR2999933B1 (fr) * | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
FR2999932B1 (fr) * | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
US9458230B2 (en) * | 2013-01-04 | 2016-10-04 | Wisconsin Alumni Research Foundation | Secretory IGA compositions, methods of making and methods of use thereof |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US9468674B2 (en) * | 2013-09-24 | 2016-10-18 | Wisconsin Alumni Research Foundation | Methods of use of secretory IgA |
EP3395351A1 (en) | 2014-12-23 | 2018-10-31 | 4D Pharma Research Limited | Immune modulation |
JP6427278B2 (ja) | 2014-12-23 | 2018-11-21 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | pirinポリペプチド及び免疫モジュレーション |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CN107847529B (zh) | 2015-06-15 | 2022-05-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
BR112017025005A2 (pt) | 2015-06-15 | 2018-08-07 | 4D Pharma Research Limited | composições compreendendo cepas baterianas |
PT3650033T (pt) | 2015-06-15 | 2022-05-25 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
MA41013A (fr) | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
BR112018013501B1 (pt) | 2015-12-29 | 2022-12-20 | N.V. Nutricia | Uso de um ingrediente fermentado e oligossacarídeo não digerível |
CN108697141A (zh) * | 2015-12-29 | 2018-10-23 | N·V·努特里奇亚 | 含有不可消化寡糖和非复制型产乳酸细菌的营养配方物 |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EA035949B1 (ru) | 2016-03-04 | 2020-09-04 | 4Д ФАРМА ПиЭлСи | Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности |
WO2017223419A1 (en) * | 2016-06-24 | 2017-12-28 | Ig Biosciences Corporation | Prebiotic neutraceutical compositions and methods of treatment using the same |
TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
MA48939B1 (fr) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
LT3638271T (lt) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterines padermes |
MD3600364T2 (ro) | 2017-06-14 | 2020-12-31 | 4D Pharma Res Ltd | Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora |
HUE053488T2 (hu) | 2017-06-14 | 2021-06-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
CN109744441A (zh) * | 2017-11-02 | 2019-05-14 | 健茂生物科技股份有限公司 | 具抗氧化功能的仙人掌果与红龙果复合发酵饮品的制备工艺 |
MX2021003224A (es) * | 2018-10-02 | 2021-05-27 | Nestle Sa | Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion. |
WO2020123121A1 (en) * | 2018-12-11 | 2020-06-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of screening antibodies for treating and/or preventing necrotizing enterocolitis (nec) |
AU2019410036A1 (en) * | 2018-12-21 | 2021-06-03 | Société des Produits Nestlé S.A. | Probiotic combination for treatment of allergic disorders |
JP7528057B2 (ja) * | 2019-03-29 | 2024-08-05 | 株式会社ヤクルト本社 | 食事由来の多糖の利用性が高い新規ビフィドバクテリウム属細菌 |
AU2020306842A1 (en) * | 2019-06-28 | 2021-12-16 | Societe Des Produits Nestle S.A. | Compositions comprising secretory IgA and probiotics |
WO2021219635A2 (en) | 2020-04-27 | 2021-11-04 | Société des Produits Nestlé S.A. | Method for producing milk like products |
AU2021263069A1 (en) | 2020-04-27 | 2022-11-10 | Société des Produits Nestlé S.A. | Method for producing milk like products |
EP4423240A1 (en) | 2021-10-27 | 2024-09-04 | Société des Produits Nestlé S.A. | Method for producing milk like products |
CN118139971A (zh) | 2021-10-27 | 2024-06-04 | 雀巢产品有限公司 | 用于生产乳样产物的方法 |
MX2024004708A (es) | 2021-10-27 | 2024-05-09 | Nestle Sa | Metodo para producir productos similares a la leche. |
WO2023073121A1 (en) | 2021-10-27 | 2023-05-04 | Société des Produits Nestlé S.A. | Method for producing milk like products |
AU2022378531A1 (en) | 2021-10-27 | 2024-04-18 | Société des Produits Nestlé S.A. | Method for producing milk like products |
WO2023118197A1 (en) | 2021-12-20 | 2023-06-29 | Société des Produits Nestlé S.A. | Secretory iga-biotic complexes and uses thereof |
CN114990004B (zh) * | 2022-04-19 | 2023-09-15 | 尚品健康科技(青岛)有限公司 | 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用 |
KR102590051B1 (ko) * | 2022-10-20 | 2023-10-16 | 주식회사 종근당바이오 | 건강한 한국인의 장내 핵심 유산균을 이용한 장내 마이크로바이옴 환경 및 장 건강 개선용 프로바이오틱스 조성물 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5589233A (en) * | 1978-12-28 | 1980-07-05 | Shogo Nakano | Preparation of additive for breeding of new born cattle |
JPH04342533A (ja) * | 1991-05-16 | 1992-11-30 | Yakult Honsha Co Ltd | IgA産生促進剤 |
JPH06234647A (ja) * | 1993-02-12 | 1994-08-23 | Yakult Honsha Co Ltd | IgA産生促進剤およびその製造法 |
JPH0761934A (ja) * | 1993-08-25 | 1995-03-07 | Yakult Honsha Co Ltd | ワクチンの効果増強剤及び効果増強食品 |
WO1997020577A1 (en) * | 1995-12-06 | 1997-06-12 | Pharma Pacific Pty. Ltd. | Improved therapeutic formulation and method |
WO2005019438A1 (ja) * | 2003-08-21 | 2005-03-03 | Otsuka Pharmaceutical Co., Ltd. | 粘膜免疫賦活作用を有する乳酸菌 |
WO2006087913A1 (ja) * | 2005-02-02 | 2006-08-24 | Meiji Dairies Corporation | 免疫賦活用組成物 |
WO2007019901A1 (en) * | 2005-08-19 | 2007-02-22 | Unilever N.V. | Food products comprising probiotic micro-organisms and antibodies |
WO2008064489A1 (en) * | 2006-12-01 | 2008-06-05 | Mcmaster University | Probiotics to inhibit inflammation |
JP2011525484A (ja) * | 2008-06-24 | 2011-09-22 | ネステク ソシエテ アノニム | プロバイオティクス、分泌型IgA及び感染症 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5531988A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Bacteria and immunoglobulin-containing composition for human gastrointestinal health |
WO2003041512A1 (en) * | 2001-11-12 | 2003-05-22 | Mars, Incorporated | Foodstuff |
US20080145420A1 (en) * | 2006-12-13 | 2008-06-19 | Simon Michael R | HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
EP2280999B1 (en) * | 2008-05-15 | 2017-09-06 | Biosys Health Inc. | Process for producing milk fractions rich in secretory immunoglobulins |
EP2127661A1 (en) * | 2008-05-27 | 2009-12-02 | Nestec S.A. | Probiotics to improve gut microbiotica |
EP2138186A1 (en) * | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
-
2008
- 2008-06-24 EP EP08158827A patent/EP2138186A1/en not_active Withdrawn
-
2009
- 2009-06-16 EP EP09769150.5A patent/EP2318046B1/en active Active
- 2009-06-16 PT PT97691505T patent/PT2318046E/pt unknown
- 2009-06-16 CA CA2727300A patent/CA2727300A1/en not_active Abandoned
- 2009-06-16 ES ES13189401.6T patent/ES2641364T3/es active Active
- 2009-06-16 CN CN200980124319.2A patent/CN102076360B/zh active Active
- 2009-06-16 ES ES09769150.5T patent/ES2447572T3/es active Active
- 2009-06-16 AU AU2009264417A patent/AU2009264417B2/en active Active
- 2009-06-16 US US13/000,666 patent/US9822167B2/en active Active
- 2009-06-16 PL PL09769150T patent/PL2318046T3/pl unknown
- 2009-06-16 JP JP2011514017A patent/JP2011525483A/ja active Pending
- 2009-06-16 WO PCT/EP2009/057453 patent/WO2009156301A1/en active Application Filing
- 2009-06-16 BR BRPI0914561A patent/BRPI0914561A2/pt not_active IP Right Cessation
- 2009-06-16 PT PT131894016T patent/PT2700412T/pt unknown
- 2009-06-16 EP EP13189401.6A patent/EP2700412B1/en active Active
-
2017
- 2017-10-19 US US15/787,904 patent/US10501530B2/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5589233A (en) * | 1978-12-28 | 1980-07-05 | Shogo Nakano | Preparation of additive for breeding of new born cattle |
JPH04342533A (ja) * | 1991-05-16 | 1992-11-30 | Yakult Honsha Co Ltd | IgA産生促進剤 |
JPH06234647A (ja) * | 1993-02-12 | 1994-08-23 | Yakult Honsha Co Ltd | IgA産生促進剤およびその製造法 |
JPH0761934A (ja) * | 1993-08-25 | 1995-03-07 | Yakult Honsha Co Ltd | ワクチンの効果増強剤及び効果増強食品 |
WO1997020577A1 (en) * | 1995-12-06 | 1997-06-12 | Pharma Pacific Pty. Ltd. | Improved therapeutic formulation and method |
WO2005019438A1 (ja) * | 2003-08-21 | 2005-03-03 | Otsuka Pharmaceutical Co., Ltd. | 粘膜免疫賦活作用を有する乳酸菌 |
WO2006087913A1 (ja) * | 2005-02-02 | 2006-08-24 | Meiji Dairies Corporation | 免疫賦活用組成物 |
WO2007019901A1 (en) * | 2005-08-19 | 2007-02-22 | Unilever N.V. | Food products comprising probiotic micro-organisms and antibodies |
WO2008064489A1 (en) * | 2006-12-01 | 2008-06-05 | Mcmaster University | Probiotics to inhibit inflammation |
JP2011525484A (ja) * | 2008-06-24 | 2011-09-22 | ネステク ソシエテ アノニム | プロバイオティクス、分泌型IgA及び感染症 |
Non-Patent Citations (6)
Title |
---|
JPN6013042487; BioMed Central Vol.7, No.1, 200709, p.86 * |
JPN6013042491; Phalipon Armelle et al.: 'Novel Functions for Mucosal SIgA' MUCOSAL IMMUNE DEGENSE: IMMUNOGLOBULIN A , 2007, p.183-202 * |
JPN6013042493; Current Pharmaceutical Biotechnology Vol.4, No.1, 2003, p.51-67 * |
JPN6013042496; Biological Chemistry Vol.380, No.11, 1999, p.1251-1262 * |
JPN6013042498; The Journal of Trauma Vol.59, No.5, 2005, p.1099-1106 * |
JPN6013042499; The Journal of Trauma Vol.64, No.6, 200806, p.1437-1442 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011525484A (ja) * | 2008-06-24 | 2011-09-22 | ネステク ソシエテ アノニム | プロバイオティクス、分泌型IgA及び感染症 |
US9173937B2 (en) | 2008-06-24 | 2015-11-03 | Nestec S.A. | Probiotics, secretory IgA and infection |
US9629908B2 (en) | 2008-06-24 | 2017-04-25 | Nestec S.A. | Probiotics, secretory IgA and infection |
Also Published As
Publication number | Publication date |
---|---|
EP2138186A1 (en) | 2009-12-30 |
ES2641364T3 (es) | 2017-11-08 |
EP2318046A1 (en) | 2011-05-11 |
AU2009264417A1 (en) | 2009-12-30 |
AU2009264417B2 (en) | 2015-04-30 |
CN102076360B (zh) | 2018-03-09 |
EP2700412B1 (en) | 2017-07-26 |
WO2009156301A1 (en) | 2009-12-30 |
PT2700412T (pt) | 2017-11-09 |
EP2700412A1 (en) | 2014-02-26 |
CN102076360A (zh) | 2011-05-25 |
ES2447572T3 (es) | 2014-03-12 |
US20180037637A1 (en) | 2018-02-08 |
US9822167B2 (en) | 2017-11-21 |
US20110268743A1 (en) | 2011-11-03 |
PL2318046T3 (pl) | 2014-05-30 |
PT2318046E (pt) | 2014-02-27 |
BRPI0914561A2 (pt) | 2015-12-15 |
CA2727300A1 (en) | 2009-12-30 |
EP2318046B1 (en) | 2013-12-04 |
US10501530B2 (en) | 2019-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10501530B2 (en) | Probiotics, secretory IgA and inflammation | |
Parvez et al. | Probiotics and their fermented food products are beneficial for health | |
EP2318047B1 (en) | Probiotics, secretory iga and infection | |
Sharma et al. | Probiotics: a comprehensive approach toward health foods | |
EP2308498A1 (en) | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life | |
US20110268702A1 (en) | Lactobacillus paracasei and weight control | |
JP2012526748A (ja) | 短時間高温処理によって抗炎症性プロファイルを有する微生物調製物が生じる | |
JP2012526749A (ja) | 非複製性微生物及びそれらの免疫促進作用 | |
CN102869366B (zh) | 过敏性腹泻的预防和治疗 | |
JP2016520305A (ja) | 消化管微生物叢中のラクノスピラ科細菌及び体重との関連性 | |
Jain et al. | Significance of probiotics and prebiotics in health and nutrition | |
Pintado et al. | Probiotics and their therapeutic role | |
AU2013263711B2 (en) | Probiotics, secretory IgA and infection | |
Swapna et al. | Probiotics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120312 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130827 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131127 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131204 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140422 |